Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
60
CPRX Quote, Financials, Valuation and Earnings
Last price:
$21.47
Seasonality move
:
24.6%
Day range:
$21.05 - $21.54
52-week range:
$15.34 - $26.58
Dividend yield:
0%
P/E ratio:
13.66x
P/S ratio:
5.05x
P/B ratio:
3.29x
Volume:
1.4M
Avg. volume:
1.4M
1-year change:
26.92%
Market cap:
$2.6B
Revenue:
$491.7M
EPS (TTM):
$1.57
Earnings Data
Next earnings date for CPRX
Aug 07
2025
Most recent earnings per share
$0.45
Missed by $0.08
(May 7/2025)
Consensus Estimate
$0.53
(May 7/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CPRX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $138.9M | -- | -- | $0.52 | -- |
| 08/07/2025 | Q2 | $140.4M | -- | -- | $0.54 | -- |
| 05/07/2025 | Q1 | $131.1M | $141.4M | $0.45 | $0.53 | -$0.08 |
| 02/26/2025 | Q4 | $134.2M | $141.8M | $0.44 | $0.55 | -$0.11 |
| 11/07/2024 | Q3 | $123.4M | $128.7M | $0.35 | $0.51 | -$0.16 |
| 08/07/2024 | Q2 | $111.9M | $122.7M | $0.33 | $0.43 | -$0.10 |
| 05/08/2024 | Q1 | $98.8M | $98.5M | $0.19 | $0.30 | -$0.11 |
| 02/28/2024 | Q4 | $105.9M | $110.6M | $0.31 | $0.46 | -$0.15 |
| 11/08/2023 | Q3 | -- | -- | -$0.29 | $0.45 | -$0.74 |
| 08/09/2023 | Q2 | -- | -- | $0.33 | $0.41 | -$0.08 |
| 05/10/2023 | Q1 | -- | -- | $0.26 | $0.31 | -$0.05 |
| 03/15/2023 | Q4 | -- | -- | $0.22 | $0.20 | $0.02 |
| 11/09/2022 | Q3 | -- | -- | $0.20 | $0.19 | $0.01 |
| 08/09/2022 | Q2 | -- | -- | $0.20 | $0.17 | $0.04 |
| 05/10/2022 | Q1 | -- | -- | $0.12 | $0.14 | -$0.02 |
| 03/16/2022 | Q4 | -- | -- | $0.09 | $0.12 | -$0.03 |
| 11/09/2021 | Q3 | -- | -- | $0.10 | $0.12 | -$0.02 |
| 08/09/2021 | Q2 | -- | -- | $0.11 | $0.10 | $0.01 |
| 05/10/2021 | Q1 | -- | -- | $0.07 | $0.09 | -$0.02 |
| 03/15/2021 | Q4 | -- | -- | $0.11 | $0.07 | $0.04 |
| 11/09/2020 | Q3 | -- | -- | $0.41 | $0.10 | $0.31 |
| 08/10/2020 | Q2 | -- | -- | $0.09 | $0.09 | -$0.00 |
| 05/11/2020 | Q1 | -- | -- | $0.10 | $0.09 | $0.01 |
| 03/16/2020 | Q4 | -- | -- | $0.07 | $0.10 | -$0.03 |
| 11/12/2019 | Q3 | -- | -- | $0.13 | $0.12 | $0.01 |
| 08/07/2019 | Q2 | -- | -- | $0.10 | $0.02 | $0.08 |
| 05/13/2019 | Q1 | -- | -- | -$0.01 | -$0.13 | $0.12 |
| 03/18/2019 | Q4 | -- | -- | -$0.14 | -- | -- |
| 11/07/2018 | Q3 | -- | -- | -$0.08 | -- | -- |
| 08/07/2018 | Q2 | -- | -- | -$0.06 | -- | -- |
| 05/09/2018 | Q1 | -- | -- | -$0.06 | -- | -- |
| 03/14/2018 | Q4 | -- | -- | -$0.06 | -- | -- |
| 11/08/2017 | Q3 | -- | -- | -$0.05 | -- | -- |
| 08/09/2017 | Q2 | -- | -- | -$0.05 | -- | -- |
| 05/10/2017 | Q1 | -- | -- | -$0.06 | -- | -- |
| 03/15/2017 | Q4 | -- | -- | -$0.05 | -- | -- |
| 11/10/2016 | Q3 | -- | -- | -$0.05 | -- | -- |
| 08/09/2016 | Q2 | -- | -- | -$0.06 | -- | -- |
| 05/10/2016 | Q1 | -- | -- | -$0.07 | -- | -- |
| 03/16/2016 | Q4 | -- | -- | -$0.07 | -- | -- |
| 11/10/2015 | Q3 | -- | -- | -$0.05 | -- | -- |
Catalyst Pharmaceuticals Earnings Questions
-
How Much did Catalyst Pharmaceuticals Generate in Revenue Last Quarter?
Catalyst Pharmaceuticals reported $141.4M worth of top line sales in its most recent quarter.
-
Did Catalyst Pharmaceuticals Beat Earnings Last Quarter?
Catalyst Pharmaceuticals announced earnings per share of $0.45 which represents a miss of analyst forecast a $0.53 per share.
-
Is Catalyst Pharmaceuticals Profitable?
Catalyst Pharmaceuticals reported $123.5M that represents $0.97 per share over the last quarter.
-
What is the Analyst Consensus for Catalyst Pharmaceuticals EPS Next Year?
Catalyst Pharmaceuticals's earnings are forecast to grow from $1.31 per share to $2.06 per share next year representing an increase of 60.35%.
-
When is Catalyst Pharmaceuticals's Earnings Date?
Catalyst Pharmaceuticals's next earnings date is August 7, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
72
SBET alert for Jul 18
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
